AA

Asif Ali Khradi

Active Director Director DIN 08003563
DIN 08003563 First appointment Dec 2017 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile

About Asif Ali Khradi

Data last updated:

Asif Ali Khradi is a Director at Etranger Pharma Private Limited (since 2017). The company operates in Food And Beverages. Etranger Pharma Private Limited reported revenue of ₹1.1 Lakh (FY 2025).

DIN 08003563
Primary Designation Director
Industry Food And Beverages
First Appointment 11 Dec 2017
Oldest Company Age 8 yrs
Largest company Etranger Pharma Private Limited · ₹1.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Etranger Pharma Private Limited U24302PN2017PTC173795
Director11 Dec 20172017₹1.1 Lakh (FY 2025)Active

Board colleagues of Asif Ali Khradi

Directorship timeline

Open interactive timeline →
Etranger Pharma Private Limited
Premium access

Shareholding and investment profile for Asif Ali Khradi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asif Ali Khradi

Asif Ali Khradi currently holds 1 directorship: Etranger Pharma Private Limited (Director, since 11 Dec 2017, revenue ₹1.1 Lakh (FY 2025)).

Asif Ali Khradi was first appointed on 11 Dec 2017 as Director at Etranger Pharma Private Limited.

The current boards of Asif Ali Khradi's companies include Mohammed Sameer Ahamadsab Kharadi (Etranger Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available